BIXT Message Board Post 9523070 | Bioxytran Inc
home / stock / bixt / bixt message board
bellaria876
()
Posted on: May/01/2023 07:01:16
A biotechnology company called Bioxytran, Inc.($BIXT) is in the clinical stages of developing novel therapies with the goal of meeting unmet medical needs in the areas of virology, degenerative diseases, and hypoxia. Prolectin-M, the top drug candidate, belongs to a brand-new class of antiviral medications made to combat galectins linked to inflammatory, fibrotic, and cancerous diseases. The other development projects for bioxytran are for the treatment of stroke and pulmonary fibrosis. There are 123,502,235 shares outstanding.
News, Short Squeeze, Breakout and More Instantly...
Bioxytran Inc Company Name:
BIXT Stock Symbol:
Market:
-
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
-
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...
-
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...